The DeSci revolution is knocking on TradFi's door. $3T in global research funding is trapped in a web of bureaucracy and gatekeepers. BioDAO, the first mover, is already deploying real capital ($7.2M) into cutting-edge quantum bio and longevity research.
Imagine TradFi realizing they can gain instant exposure to groundbreaking scientific breakthroughs. Game over. While everyone's chasing AI hype and fleeting memes, BioDAO is quietly positioning itself to capitalize on a $3T market ripe for disruption. Sometimes the most significant opportunities arise when no one is looking.